Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Looks like you could have waited, or better yet, not even have bothered
Volume sucks
Credit on the thoughtful pump post though, next time try these ~~~~~
Great time to grab some $POWN @.035
I was going to wait until 2013 to unleash my 2013 Stock of the Year, but it appears the time is right to start to get the word out on ADIA.
The float is only 13.8M (O/S around 70M), and the company has been doing some great things behind the scenes. For whatever reason, the following has not been PR'd YET, but was sent in an e-mail to customers last month:
"Adia Nutrion On-the-Go Probiotics is now approved to be in all of the Whole Foods Southern Pacific Region. This means we're expanding our Whole Foods stores from 13 to 44! "We love being a 'local' supplier with Whole Foods Market here in Southern California. Now we have the opportunity to expand our footprint and put Adia Nutrition in the hands of Whole Foods Market customers in Arizona and Nevada, as well as Whole Foods customers up the coast to Santa Barbara." (April Nugent/Co-founder)"
The fact alone that they have their foot in the door at Whole Foods is huge. It should only continue to grow their sales. The company is also introducing their products in China and Hong Kong, so the growth in 2013 could be enormous.
They also just started posting on their company blog again, so I'm thinking they may be gearing up to make more regular announcements now:
http://kindbacteria.com/
Keep that crap to yourself
eom
Building Turbines Announces the Award of the First, in a Series of Sales Contracts
http://finance.yahoo.com/news/building-turbines-announces-award-first-121500230.html
Very nice news!
BLDW
PS
ALQA - DD Notes
----------------------------------------------------------
latest newsletter
ALQA ~ Big Upside Short term (Large Shareholder of ALQA is CEO of 34BB Teva).. Members do not miss out on ALQA.. We are now calling ALQA the Top Best FDA Approved Biotech Play in the Otcmarkets.. We feel ALQA will be on Fire next week so take advantage of it now before Thanksgiving or on Friday (but its only a half day trading on Friday so it might be hard to get shares)...
ALQA Huge news and very Bullish ~ One of the largest shareholders and Institutions in ALQA is Frost Gamma ...
Frost Gamma is the investment arm of Dr. Phillip Frost, the current Chairman of Teva Pharmaceuticals (a $34BB company). Dr. Frost amassed his multi-billion dollar fortune in the pharmaceutical industry and his Frost Gamma Trust invests in numerous companies in the healthcare space...
ALQA ~ We are hearing Big things are in the pipeline for ALQA and we feel now is the time to take advantage of ALQA being quite prior to Thanksgiving. ALQA should breakout next week but we feel ALQA will be hard to time so Don't Miss out on ALQA while its cheap and quite. A lot of our Members chased our other play and it ended up running over 2,100% ...
read full: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=81709227
**********************************************************
recent news/filings
Nov 19, 2012 Alliqua to Explore Business Development Efforts for Hydrogel Transdermal Delivery Platform in the Cosmeceutical Industry
Alliqua announced the Company's exploration of business development efforts for its proprietary transdermal delivery platform in the cosmeceutical industry.
According to market research data from the Freedonia Group, the cosmeceutical market reached $6.4 billion in 2010 and is projected to grow to $8.5 billion by 2015, largely fueled by consumers searching to stave off the physical signs of aging.
read full: http://finance.yahoo.com/news/alliqua-explore-business-development-efforts-123000680.html
**********************************************************
Nov 15, 2012 Alliqua Appoints Dr. Joseph Laudano as Vice President of Medical Affairs to Support the Market Expansion of Alliqua's SilverSeal Products and Future Clinical Development
appointment of Joseph Laudano, Pharm.D. to the newly created position of Vice President, Medical Affairs to support the market expansion of Alliqua's SilverSeal® products as well as other future clinical developments. Dr. Laudano will lead the development of a medical affairs team at Alliqua as the company now begins to step up the marketing efforts for our proprietary 510K FDA approved SilverSeal® hydrogels for wound care. He will also play a key role in the planning and clinical development of our platform for transdermal drug delivery
Commenting on the appointment, James Sapirstein, CEO of Alliqua stated, "We are very pleased to have an industry veteran of such high caliber join our team here at Alliqua. One of my primary near term goals as CEO of this company is to put the right people in place that can deliver on the rich potential of our proprietary technology as well as our future strategic plans. Joe has extensive experience in some key therapeutic areas such as dermatology and infectious diseases, which I believe align nicely with Alliqua's future needs as we build this organization."
read full: http://finance.yahoo.com/news/alliqua-appoints-dr-joseph-laudano-123000587.html
**********************************************************
Nov 14, 2012 ALLIQUA, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Change in Directors or Principal Officers
read full: http://biz.yahoo.com/e/121114/alqa8-k.html
**********************************************************
Nov 13, 2012 Alliqua Launches New Sales Initiative for SilverSeal(R) Hydrogels at Desert Foot 2012 Conference in Arizona on November 14-16
Alliqua's manufacturing facility has a current production capacity to support approximately $80 million in sales of hydrogels on an annual basis with room for further expansion. With the overall market for hydrogels expected to exceed $1 billion in the next three years according to MarketsandMarkets, management intends to aggressively build its own proprietary line of hydrogels and provide private label products to other companies to rapidly expand its plant utilization rates.
Commenting on the marketing efforts, Mr. James Sapirstein, CEO of Alliqua, commented, "As we look to build Alliqua for the future, it is important to focus on two important facets of the company. The launch of this sales effort for our hydrogels is really the low hanging fruit for us in that we have a superior product and the production capability to generate substantial near term revenue without the need for large capital expenditures. If we build that business as we expect we can, we will be able to utilize the cash generated from those operations to invest in the other aspect of our business which is using our platform for drug delivery. We believe that success in drug delivery will enable us to tap into vast pharmaceutical markets and build our company into a truly world class organization for the benefit of our shareholders."
read full: http://finance.yahoo.com/news/alliqua-launches-sales-initiative-silverseal-123000151.html
**********************************************************
chart
golden cross coming!!
ticker: $ALQA
isin code: US0196211017
company name: Alliqua, Inc.
company website: http://www.alliqua.com - http://alliqua1.nextmp.net
incorporated In: FL, USA
sos filings: http://www.sunbiz.org/scripts/cordet.exe?action=DETFIL&inq_doc_number=P97000090722&inq_came_from=NAMFWD&cor_web_names_seq_number=0002&names_name_ind=&names_cor_number=&names_name_seq=&names_name_ind=&names_comp_name=ALLIQUA&names_filing_type=
latest filigns: http://www.otcmarkets.com/stock/ALQA/filings
latest financials: http://www.otcmarkets.com/stock/ALQA/financials
latest news: http://www.otcmarkets.com/stock/ALQA/news - http://finance.yahoo.com/q/h?s=ALQA+Headlines
last known share structure:
Shares Outstanding: 234,502,434 (a/o Aug 14, 2012)
Float: 206,571,658 (a/o Apr 14, 2011)
Authorized Shares: 500,000,000 (a/o Apr 14, 2011)
Par Value: 0.001
Insider transactions: http://finance.yahoo.com/q/it?s=ALQA+Insider+Transactions
Business Description: Alliqua, Inc., a biomedical products company, through its subsidiaries, focuses on the development and manufacture of proprietary technologies in the fields of drug delivery, advanced wound care, and liver health preservation. The company intends to develop, manufacture, and market active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform. It also manufactures custom hydrogels that are used for transdermal drug delivery, wound care, medical diagnostics, and cosmetics. In addition, Alliqua offers HepaMate, an extracorporeal cell-based bioartificial liver system to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the severe forms of liver failure.
$ALQA Products and Services: http://alliqua1.nextmp.net/products-and-services.html
major holdings: http://data.cnbc.com/quotes/ALQA/tab/8.1
HARBORVIEW ADVISORS, LLC now has a total of 46.639.150 shares, they bought more in Nov -> http://biz.yahoo.com/t/38/8437.html
THURSDAY'S WATCHLIST: TODAY'S PERFORMANCE: A Day of CORRECTION> AS IS: -10.59%, 10%STOP: -3.99%, BP$: -1.32% Considering how the first 3 days of the week went, I knew a bleeder was coming. The best strategy is if the market is not looking good, don't trade. The next best strategy is SET YOUR STOP-LOSS. Will be posting a sticky on exactly how to trade using the WATCHLIST for those with any questions concerning it. The rest know how to use it as an informative tool together with level 2 to work a bit of wealth.
DNDT gained 26% yesterday on massive volume. I had expected there to be less shares sold around .005, but a lot of people got a nice bargain there, and the big seller ended the day at .006.
Besides this primary seller through ATDF, there are very few offers of any size below .03. Once the seller is done (and he/she may be close following yesterday's volume), there is a good chance to see DNDT rise quickly from the subbies to multiple pennies. Just a couple months ago, we saw .06 on a small mini-run. My expectation is for higher gains this time around, as this already-profitable company has several other acquisition announcements expected to occur in the near future.
DNDT also has the same management team as JAQC, which was once at these same levels and broke $1.00 earlier this year. DNDT is working towards the establishment of a major, international holding company, and right now appears to be a great entry point for investors.
Daily Chart:
MSVS hit 52 week high
gem long
thanks Robi I play these a lot.
I second that weeeeeeeeeeeeeeeeeeeee and add yeahhhhhhhhhh!!!
thanks my friend ~ going forward I look to provide some trading ideas as well here - I appreciate all you do
I am busy as heck with PSS, but need to give some time here as well
thanks again - you are The WV~
Weeeeeeeeeeeeeeeeeeeeeeeeeeeee
Awesome decision brother.
I appreciate it , which I'm sure you know already. I will continue to provide quality Ideas for trading on the low end! I'm sure you know the more you tweek your charting the better at predicting you get so I will continue fine-tuning to better my analysis.
thanks for the watchlists and updates
made you a mod~
GMXS should go on immediate watch list.
Today's Performance: AS IS: +1.23%, 10%STOP: +3.65%, BP$: +3.17% EOW Daily Gain: +2.31%, 25Week Cumulative: +2302%
WEDNESDAY'S PERFORMANCE: AS IS: +9.97%, 10%STOP: +11.04%, BP$: +11.84% Tomorrow's Watchlist should be out sometime between tonight and tomorrow morning. All dependent on how much alcohol is consumed!
COIN sucks
eom
Yeah we have had a basher on board that is relentless, he is scaring all traders but keep an eye on it as the DOW has a major reversal going on now and like I said NO dilution...
Playing ROSV...cause it's nice and shady...those are the best ones to trade :) weeeeee
Today's Performance: AS IS: +4.58%, 10%STOP: +4.58%, BP$: +5.27%, EOW DAILY: +4.77%, 25Week Cumulative: +2109%
SBRH In the middle of a HUGE correction, Monday .0003 close today .0009 up ticking one tick a day
DNYS ~ .14 close! PR is near my friends IMO :) check the board for DD links...
Yeah converted organics smell a lot like manure.
because it's a dilution pig with a history of R/S... the most recent of which was back in march of this year?
yah I pass too.
It dropped 40 percent today brother. Appears the street isn't as enthused as you.
BLDW
International Businessman, Paul Getty, has joined the Building Turbines team as Head of a New Strategic Advisory Board.
http://finance.yahoo.com/news/building-turbines-pleased-announce-addition-120400309.html
PS
Followers
|
155
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
17953
|
Created
|
01/28/11
|
Type
|
Free
|
Moderator robisstocks | |||
Assistants |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |